Omega-3 PUFA

DIETARY_SUPPLEMENT2 trials

Sponsors

University of Manchester, Jagiellonian University

Conditions

Cardiovascular DiseasesSkin CancerType 2 Diabetes

Unknown Phase

An Immunonutritional Approach to the Prevention of Skin Cancer

CompletedNCT01032343

University of ManchesterSkin Cancer

Start: 2008-07-31End: 2010-11-30Updated: 2013-08-22

Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.

CompletedNCT02178501

Jagiellonian UniversityCardiovascular Diseases, Type 2 Diabetes

Start: 2013-01-31End: 2016-02-29Updated: 2016-11-29

Related Papers

Treatment with high-dose n-3 PUFAs has no effect on platelet function, coagulation, metabolic status or inflammation in patients with atherosclerosis and type 2 diabetes.

2017-04-1465 citations

Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses.

2013-01-3031 citations